These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36928853)

  • 1. Targeted Treatments for Fragile X Syndrome.
    Johnson D; Clark C; Hagerman R
    Adv Neurobiol; 2023; 30():225-253. PubMed ID: 36928853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.
    Lozano R; Martinez-Cerdeno V; Hagerman RJ
    Curr Pharm Des; 2015; 21(34):4972-4979. PubMed ID: 26365141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Targeted Treatments for Fragile X Syndrome.
    Protic D; Salcedo-Arellano MJ; Dy JB; Potter LA; Hagerman RJ
    Curr Pediatr Rev; 2019; 15(4):251-258. PubMed ID: 31241016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of metformin in fragile X syndrome: An open-label study.
    Proteau-Lemieux M; Lacroix A; Galarneau L; Corbin F; Lepage JF; Çaku A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110307. PubMed ID: 33757860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment.
    Palumbo JM; Thomas BF; Budimirovic D; Siegel S; Tassone F; Hagerman R; Faulk C; O'Quinn S; Sebree T
    J Neurodev Disord; 2023 Jan; 15(1):1. PubMed ID: 36624400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
    Berry-Kravis E
    Pediatr Neurol; 2014 Apr; 50(4):297-302. PubMed ID: 24518745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for Fragile X Syndrome: Progress to Date.
    Davenport MH; Schaefer TL; Friedmann KJ; Fitzpatrick SE; Erickson CA
    Drugs; 2016 Mar; 76(4):431-45. PubMed ID: 26858239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin as targeted treatment in fragile X syndrome.
    Dy ABC; Tassone F; Eldeeb M; Salcedo-Arellano MJ; Tartaglia N; Hagerman R
    Clin Genet; 2018 Feb; 93(2):216-222. PubMed ID: 28436599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parent and Caregiver Perspectives towards Cannabidiol as a Treatment for Fragile X Syndrome.
    Maertens M; Silver H; Dixon Weber J; Rosselot H; Lozano R
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.
    Heussler H; Cohen J; Silove N; Tich N; Bonn-Miller MO; Du W; O'Neill C; Sebree T
    J Neurodev Disord; 2019 Aug; 11(1):16. PubMed ID: 31370779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.
    Müller AR; den Hollander B; van de Ven PM; Roes KCB; Geertjens L; Bruining H; van Karnebeek CDM; Jansen FE; de Wit MCY; Ten Hoopen LW; Rietman AB; Dierckx B; Wijburg FA; Boot E; Brands MMG; van Eeghen AM
    BMC Psychiatry; 2024 Jan; 24(1):23. PubMed ID: 38177999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin treatment in young children with fragile X syndrome.
    Biag HMB; Potter LA; Wilkins V; Afzal S; Rosvall A; Salcedo-Arellano MJ; Rajaratnam A; Manzano-Nunez R; Schneider A; Tassone F; Rivera SM; Hagerman RJ
    Mol Genet Genomic Med; 2019 Nov; 7(11):e956. PubMed ID: 31520524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders.
    Gantois I; Popic J; Khoutorsky A; Sonenberg N
    Annu Rev Med; 2019 Jan; 70():167-181. PubMed ID: 30365357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases.
    Protic D; Aydin EY; Tassone F; Tan MM; Hagerman RJ; Schneider A
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00745. PubMed ID: 31104364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
    Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
    J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).
    Berry-Kravis E; Hagerman R; Budimirovic D; Erickson C; Heussler H; Tartaglia N; Cohen J; Tassone F; Dobbins T; Merikle E; Sebree T; Tich N; Palumbo JM; O'Quinn S
    J Neurodev Disord; 2022 Nov; 14(1):56. PubMed ID: 36434514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.
    Pop AS; Gomez-Mancilla B; Neri G; Willemsen R; Gasparini F
    Psychopharmacology (Berl); 2014 Mar; 231(6):1217-26. PubMed ID: 24232444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular medicine of fragile X syndrome: based on known molecular mechanisms.
    Luo SY; Wu LQ; Duan RH
    World J Pediatr; 2016 Feb; 12(1):19-27. PubMed ID: 26547211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X Syndrome: Lessons Learned and What New Treatment Avenues Are on the Horizon.
    Hagerman RJ; Hagerman PJ
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():365-381. PubMed ID: 34499526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome.
    Jasoliya M; Bowling H; Petrasic IC; Durbin-Johnson B; Klann E; Bhattacharya A; Hagerman R; Tassone F
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32531912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.